Renal cell carcinoma 4

Common Name(s)

Renal cell carcinoma 4

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Renal cell carcinoma 4" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Renal cell carcinoma 4" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Renal cell carcinoma 4" returned 23 free, full-text research articles on human participants. First 3 results:

Attenuation of krüppel-like factor 4 facilitates carcinogenesis by inducing g1/s phase arrest in clear cell renal cell carcinoma.
 

Author(s): Erlin Song, Xin Ma, Hongzhao Li, Peng Zhang, Dong Ni, Weihao Chen, Yu Gao, Yang Fan, Haigang Pang, Taoping Shi, Qiang Ding, Baojun Wang, Yu Zhang, Xu Zhang

Journal:

 

Krüppel-like factor 4 (KLF4) is a transcription factor with diverse functions in various cancer types; however, the function of KLF4 in clear cell renal cell carcinoma (ccRCC) carcinogenesis remains unknown. In this study, we initially examined KLF4 expression by using a cohort of ...

Last Updated: 17 Jul 2013

Go To URL
Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma.
 

Author(s): Nelson G Ordóñez

Journal: Mod. Pathol.. 2013 Aug;26(8):1132-43.

 

Both mesotheliomas and renal cell carcinomas can present a wide variety of cytomorphologic features and histologic patterns. Because of this, renal cell carcinomas metastatic to the pleura and lung can be confused with mesotheliomas. Recently, a variety of positive carcinoma markers, ...

Last Updated: 1 Aug 2013

Go To URL
Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis.
 

Author(s): Xiwei Wu, Lihong Weng, Xuejun Li, Chao Guo, Sumanta K Pal, Jennifer M Jin, Yuping Li, Rebecca A Nelson, Bing Mu, Susan H Onami, Jeffrey J Wu, Nora H Ruel, Sharon P Wilczynski, Hanlin Gao, Maricela Covarrubias, Robert A Figlin, Lawrence M Weiss, Huiqing Wu

Journal: PLoS ONE. 2012 ;7(5):e35661.

 

Renal cell carcinoma (RCC) metastasis portends a poor prognosis and cannot be reliably predicted. Early determination of the metastatic potential of RCC may help guide proper treatment. We analyzed microRNA (miRNA) expression in clear cell RCC (ccRCC) for the purpose of developing ...

Last Updated: 24 May 2012

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Renal cell carcinoma 4" returned 0 free, full-text review articles on human participants.

 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Study of Sunitinib Administered as 4/2 vs. 2/1 Schedule in Advanced Renal Cell Carcinoma (RCC)
 

Status: Recruiting

Condition Summary: Metastatic Renal Cell Carcinoma

 

Last Updated: 5 Dec 2011

Go to URL
Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib
 

Status: Not yet recruiting

Condition Summary: Renal Cell Cancer

 

Last Updated: 28 Apr 2009

Go to URL
Chemokines and Renal Cancer
 

Status: Recruiting

Condition Summary: Carcinoma; Carcinoma Renal Cell; Kidney Neoplasms; Kidney Diseases; Chemokines

 

Last Updated: 31 Jan 2014

Go to URL